Cointime

Covaxx

company

About

Covaxx is a biotech company developing diagnostic tests and vaccines designed to cure COVID-19.

  • Hauppauge,New York,United States
  • 11 - 50

Highlights

Total Funding Amount
$32.86M
Funding Rounds
2
Investors
1
Employee Profiles
4

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$14.84M
Industries
Biotechnology,Health Diagnostics
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Covaxx
Also Known As
C19 Corp.,C19 Corporation

Covaxx has announced that their vaccine development efforts will be consolidated under the newly formed holding company, Vaxxinity, Inc. The company is headquartered in Dallas, Texas, and has operations in Asia, Europe, Latin America, and the United States. Vaxxinity has acquired wholly-owned subsidiaries COVAXX and United Neuroscience. Vaxxinity's Board of Directors has been appointed by Lou Reese, the Executive Chairman of COVAXX. Mei Mei Hu, former CEO of COVAXX, has been named CEO of Vaxxinity.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$32.86M
Covaxx has raised a total of $32.86M in funding over 2 rounds. Their latest funding was raised on Aug 7, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 7, 2020 Series Unknown $18.01M 1 — — Detail
Apr 3, 2020 Series Unknown $14.84M — — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Covaxx is funded by 1 investors. Ministry of Health and Welfare (Taiwan) are the most recent investors.
Investor Name Lead Investor Funding Round
Ministry of Health and Welfare (Taiwan) — Series Unknown

Employee Profiles

Number of Employee Profiles
4
Covaxx has 4 current employee profiles, including Executive Mei Mei Hu
Mei Mei Hu
Executive
Derek Collison
Employee
George Siber
Employee
Lou Reese
Executive
Cointime
Chủ Đề
Công Ty